Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Atrial functional tricuspid regurgitation (A-FTR) has emerged as a newly recognized phenotype of functional tricuspid regurgitation (FTR), occurring in patients with atrial fibrillation and right atrial (RA) dilation but normal right ventricular (RV) size and function. Its prevalence, echocardiographic features and prognosis have not yet clarified since most evidence to date has included indiscriminately FTR patients with A-FTR and ventricular form (V-FTR). Aim Aim of this study was to investigate the differences between these two phenotypes of FTR in terms of clinical correlates, echocardiographic aspects and prognosis. Material and methods A total of 180 consecutive patients with moderate to severe FTR referred for echocardiography in two Italian centers were retrospectively enrolled. A-FTR was defined according to most recent guidelines criteria. The composite endpoint of death for any cause and heart failure (HF) hospitalization was used as primary outcome of this analysis; secondary end point was HF-hospitalization. Results. Patients with A-FTR were 30% of the population; they were older than those one with V-FTR; with higher systolic blood pressure and less advanced symptoms (table 1). Chronic obstructive pulmonary disease was more prevalent in V-FTR. Patients with V-FTR had larger 3D-derived right ventricle (RV) volumes, both diastolic and systolic, while right ventricle ejection fraction (RVEF) was similar. RV functional parameters as TAPSE, RVFWLS, RVGLS were significantly lower in the V-FTR patients as well as all the parameters of RV-pulmonary arterial (PA) coupling. After a median follow-up of 24 months (IQR: 2-48), 72 patients (40%) reached the primary end-point and 64 (36%) hospitalized for HF. The rate of composite end point tended to be lower in A-FTR than in V-FTR ( 29% vs 44%, p value: 0,1); the rate of hospitalization for HF was higher in V-FTR patients (22% vs 41%, p value: 0,04) (Kaplan Meier shown in figure1). Correlates of combined end point in both groups were: functional class of dyspnea (NYHA class III-IV vs I-II), severe TR grade (HR in V-FTR: 2,88 [1.63-5.06], P <0,01; HR in A-FTR: 8[3-17], P <0.01); RV volumes, RA volumes (table 2). Estimated SPAP as well as all the parameters of RV function and of RV-PA coupling were correlates of prognosis only in V-FTR; conversely, parameters of TA dimensions were related to combined end point in A-FTR phenotype, while RV function and RV-PA coupling indexes did not. Conclusions Patients having A-FTR have an incidence of combined end point slightly different, without reaching a statistically significant difference, thus remarking the fact that A-FTR could not be considered "more benign" and should therefore be targeted. Prognostic predictors are different between A-.FTR and V-FTR patients. Abstract Figure.

Prevalence, Characteristics, and Impact of Frailty in Patients with Functional Tricuspid Regurgitation.

The prevalence of frailty and its effect on the outcome in cardiac resynchronization therapy patients

Exercise Capacity and Clinical Outcomes in Chronic Heart Failure Patients with Mild Tricuspid Regurgitation

Impact of the Hospital Frailty Risk Score on Outcomes After Transcatheter Aortic Valve Replacement in Late Elderly Patients

Abstract 14268: Prognostic Value of Clinical and Echocardiographic Factors in Atrial Functional Tricuspid Regurgitation

Atrial and ventricular phenotypes in a cohort of patients with functional tricuspid regurgitation: clinical, echocardiographic and prognostic aspects

Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure

Usefulness of frailty assessment using the revised Japanese version of the Cardiovascular Health Study on the prediction of clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Implication of Different Frailty Criteria in Older People with Atrial Fibrillation: a Prospective Cohort Study

Prevalence, Incidence, and Outcomes of Diastolic Dysfunction in Isolated Tricuspid Regurgitation: Perhaps Not Really "Isolated"?

Prevalence and Prognostic Implications of Changes in Tricuspid Regurgitation Severity in Acute Heart Failure

Frailty and heart failure: State-of-the-art review

Clinical performance and exercise hemodynamics in patients with severe secondary tricuspid regurgitation and chronic atrial fibrillation

Abstract 9559: Isolated Functional Tricuspid Regurgitation: Importance of Atrial Fibrillation and Right Atrial Remodeling and Prognostic Significance

Frailty, periinterventional complications and outcome in patients undergoing percutaneous mitral and tricuspid valve repair

Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction: a retrospective longitudinal study

Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation

Frailty and Post-hospitalization Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

Effect of severe tricuspid regurgitation on the prognosis of patients with atrial functional mitral regurgitation: the REVEAL-AFMR registry

The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications

Frailty prevalence in older adults with atrial fibrillation: A cross-sectional study in a resource-limited setting